RANOS
Latest updated Report. Hope the link works.
Conservatively done, however:
- Adding this digital/telemedicine upside into our forecasts would increase our risked (10%) Sofdra NPV13 valuation to $0.74/sh; Unrisked (post FDA approval) with an NPV10 it would further increase to $0.95/sh.
Worth a read.
BOT - Anything but charting, page-8499
-
- There are more pages in this discussion • 1,825 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.8¢ |
Change
0.003(0.60%) |
Mkt cap ! $770.9M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 43.5¢ | 41.0¢ | $2.781M | 6.570M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 332863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 146518 | 10 |
View Market Depth
| Last trade - 15.04pm 06/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |